Professional
Added to YB: 2023-03-23
Pitch date: 2023-03-23
TCRR [bullish]
TCR2 Therapeutics Inc.
+8.82%
current return
Author Info
Special Situation Investments focuses on event-driven trades and low risk arbitrage opportunities with short term catalysts. Sign up for the newsletter.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
TCR2 Therapeutics Inc., a clinical-stage cell therapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer.
Market Cap
$58.1M
Pitch Price
$1.36
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.52
P/E
-0.35
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
TCR2 Therapeutics (TCRR) - Merger Arbitrage - 14% Upside
A summary for this pitch has not been created yet.
Read full article (1 min)